Found 221 matching trials
A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer
PHASE2Evaluate the efficacy and safety of Disitamb Vedotin combined with pyrotini...
Location
Jiangsu Provincial People's Hospital
Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer
PHASE2This trial is a multicenter, open-label, phase II trial conducted at 23 cen...
Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer
PHASE2In this single arm, open label, phase 2 trial, operable patients with stage...
Location
Yantai Yuhuangding Hospital
Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)
N/AThis study aims to describe the different treatment time, treatment mode an...
Location
Henan cancer hospital
Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer
PHASE3This is an open label, phase III study evaluating the efficacy and safety o...
Location
Multiple Locations
Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer
PHASE2This study is a single-center, single-arm, prospective phase II clinical st...
Location
Tianjin Cancer Hospital
Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer
PHASE2According to the investigator's judgment, there are concomitant diseases th...
Location
Shengjing Hospital of China Medical University
Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)
PHASE2This study is a prospective, single-arm, phase II clinical study for patien...
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
PHASE2This study is a one-arm, open, phase II clinical study, and the study subje...
Location
Peking University Cancer Hospital
Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer
PHASE1This is a Phase 1, open-label study to evaluate the safety and the efficacy...
Location
Sun Yat-Sen University Cancer Center